DNA
Ginkgo Bioworks Holdings
$7.45
+$0.09 (+1.22%)Jul 27, 2026
Key metrics
The numbers that frame DNA today
- Market cap
- $486.67M
- P/E (TTM)
- -1.6
- EV / FCF
- -4.5
- Gross margin
- 73.1%
- EV / Sales
- 5.3
- ROIC
- -24.4%
- Div yield
- 0%
- Debt / equity
- 0.9
- 52wk Low
- $5.37
- 52wk High
- $17.58
Growth
Revenue and earnings trend for DNA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DNA
Is Ginkgo Bioworks Holdings a good buy?
No. Ginkgo Bioworks Holdings has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Ginkgo Bioworks Holdings is selling at a very high price.
What is the market capitalization of DNA?
Ginkgo Bioworks Holdings's market capitalization is $486.67M.
What is the P/E ratio for DNA stock?
Ginkgo Bioworks Holdings's current P/E ratio is -1.6.
What is the 52-week high for DNA stock?
The 52-week high for Ginkgo Bioworks Holdings is $17.58. The current close of $7.45 is 57.6% below that high.
What is the 52-week low for DNA stock?
The 52-week low for Ginkgo Bioworks Holdings is $5.37. The current close of $7.45 is 38.7% above that low.
Does DNA stock pay dividends?
Ginkgo Bioworks Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DNA?
Ginkgo Bioworks Holdings's Debt / Equity ratio is 0.93.